查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930157

解剖病理市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察，2026-2034年

Anatomic Pathology Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 请询问到货日

价格

解剖病理市场成长驱动因素

受慢性病盛行率上升和对精准疾病诊断需求不断成长的推动，全球解剖病理市场预计在预测期内将显着成长。该市场预计在2025年达到 377.4亿美元，并在2026年达到 402.9亿美元。预计到2034年将进一步成长至 740.4亿美元，年复合成长率（CAGR）为 7.90%。北美地区在2025年将以 36.18%的市场占有率领先，这主要得益于其先进的医疗基础设施、高检测量以及创新病理技术的广泛应用。

解剖病理学是一门透过检查组织、器官和体液来诊断疾病的专科。它在癌症检测、发炎性疾病评估和慢性病管理中发挥着非常重要的作用。根据美国癌症协会（2025年）估计，美国每年新增癌症病例约200万例，这进一步推动了对解剖病理学检测（包括解剖病理学检测、免疫组织化学和分子诊断）的需求。

主要市场参与者，例如 Cardinal Health、F. Hoffmann-La Roche Ltd. 和 Leica Microsystems，正致力于开发创新仪器、耗材和人工智慧驱动的数位病理学解决方案，以满足不断成长的患者群体和对早期疾病检测的需求。

市场动态

市场驱动因素

癌症、自体免疫疾病和发炎性肠道疾病等慢性疾病的日益普遍，推动解剖病理学产品的应用。根据美国疾病管制与预防中心（CDC）（2024）的资料显示，发炎性肠道疾病影响着美国 240万至 310万人。此外，早期检测和筛检技术的进步，以及人工智慧（AI）与数位解剖病理学的融合，推动全球检测量的成长。

其他主要成长驱动因素包括：

  • 精准医疗的兴起：生物标记检测与组织解剖病理学的融合，能够实现个人化治疗决策。
  • 医疗基础设施的扩建：医院、诊断中心和实验室现代化方案的增加，尤其是在亚太和拉丁美洲地区，推动市场渗透。
  • 支持性偿付计画：政府和保险公司扩大诊断检测的覆盖范围，特别是癌症筛检。

市场限制因子

全切片成像系统、切片机、染色机和组织处理系统等先进产品的高昂成本限制了它们的普及，尤其是在中小型实验室。额外的营运成本、切片製备和监管合规性进一步限制了产品的普及。

市场机会

针对癌症治疗的临床试验的增加，为製造商和检测机构与合约研究组织（CRO）合作创造了机会。生物标记评估、基于组织的伴随诊断和组织解剖病理学评估在免疫疗法和基因疗法的临床试验中变得越来越重要，推动了对先进分子解剖病理学和数位解剖病理学平台的需求。

市场挑战

  • 发展中国家的诊断限制：发表时间延迟、熟练病理学家短缺以及实验室基础设施不足阻碍了早期检测。
  • 监管障碍：基于人工智慧和分子解剖病理解决方案的漫长验证和审批流程延缓了商业化进程。
  • 替代技术的出现：液体切片检查和先进影像技术正开始补充或取代传统病理方法。

市场趋势

人工智慧、数位解剖病理、分子诊断和全切片成像等技术进步改变市场格局。根据梅奥诊所（2025年）预测，超过 50%的外科病理病例将数位化，并透过数位平台进行解读，提高诊断准确性和工作流程效率。

市场区隔分析

依类型

市场分为产品与服务两大类。产品（设备和耗材，例如切片机、染色机和组织处理系统）占据市场主导地位，预计到2026年将占据 63.13%的市场占有率，这主要得益于解剖病理学检测的增加和监管审批的推进。

例如：2024年 5月，Indica Labs 的主要诊断数位平台 "HALO AP Dx" 获得 FDA 批准，进一步丰富了其产品组合。

依应用

  • 疾病诊断预计将占据市场主导地位，预计到2026年将占据 71.64%的市场占有率，这主要得益于癌症和自体免疫疾病等慢性病盛行率的上升。
  • 药物研发领域将以 7.7%的年复合成长率成长。

依技术划分

  • 受慢性病发病率上升的推动，组织解剖病理学预计在2026年占据45.62%的市场占有率。
  • 分子解剖病理学预计将以8.3%的年复合成长率成长，这反映了先进诊断方法的日益普及。

依最终使用者划分

  • 受医疗机构数量增加和患者群体扩大的推动，医院和门诊手术中心（ASC）将在2026年占据56.54%的市场占有率。
  • 临床实验室预计将以7.7%的年复合成长率成长。

区域展望

  • 北美：预计2025年市场规模将达到136.5亿美元，2026年将达到146.3亿美元，其中美国将占126.9亿美元。这主要得益于高检测量和先进的基础设施。
  • 欧洲：预计2026年市场规模将达到99.8亿美元，主要得益于监管合规、数位化解剖病理学的应用以及医疗保健服务的改善。
  • 亚太地区：预计2026年市场规模将达到117.8亿美元，其中印度将占24亿美元，中国将占36.2亿美元。
  • 拉丁美洲：预计到2026年，市场规模将达到 25.3亿美元。
  • 中东和非洲：预计到2025年，GCC地区的市场规模将达到 3.7亿美元。

主要产业趋势

  • 2025年 9月：Labcorp 收购Roche的VENTANA DP 600 和 DP200 扫描器。
  • 2025年 9月：StatLab Medical Products 推出 PiSmart S1 玻片印表机。
  • 2025年 7月：PathAI 推出精准病理网路（PPN），该网路配备 AISight 1 IMS。
  • 2025年 3月：Techcyte 推出其 Fusion SaaS 平台，该平台整合了解剖学和临床工作流程。
  • 2024年8月：StatLab收购Diapath S.p.A.，以增强其市场占有率。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 主要疾病流行情况、主要国家和地区（2025/2026年）
  • 新产品发布、主要参与者
  • 关键产业趋势 - 併购与合作

第5章 全球解剖病理学市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测 - 依类型划分
    • 产品
      • 设备
      • 耗材
    • 服务
  • 市场分析、洞察与预测 - 依应用划分
    • 疾病诊断
    • 药物研发
    • 其他
  • 市场分析、洞察与预测 - 依技术划分
    • 组织解剖病理学
    • 免疫组织化学（IHC）
    • 原位杂交
    • 分子解剖病理学
    • 其他
  • 市场分析、洞察与预测 - 依最终用户划分
    • 医院及门诊手术中心（门诊手术中心）
    • 专科诊所
    • 临床实验室
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美解剖病理市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲解剖病理市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第8章 亚太地区解剖病理学市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 澳洲
    • 中国
    • 印度
    • 东南亚
    • 亚太其他地区

第9章 拉丁美洲解剖病理学市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区美国

第10章 中东和非洲解剖病理学市场分析、洞察与预测（2021-2034年）

  • 依国家划分
    • GCC
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市场占有率分析（2025年）
  • 公司简介
  • Cardinal Health
  • F. Hoffmann La. Roche Ltd.
  • Avantor, Inc.
  • Danaher Corporation
  • SLMP, LLC.
  • Agilent Technologies, Inc.
  • Indica Labs, LLC.
  • Hologic, Inc.
Product Code: FBI114388

Growth Factors of anatomic pathology Market

The global anatomic pathology market is poised for substantial growth over the forecast period, driven by the increasing prevalence of chronic diseases and the rising demand for accurate disease diagnosis. The market was valued at USD 37.74 billion in 2025, projected to reach USD 40.29 billion in 2026, and is expected to grow to USD 74.04 billion by 2034, reflecting a CAGR of 7.90%. North America led the market in 2025 with a 36.18% share, attributed to advanced healthcare infrastructure, high test volumes, and widespread adoption of innovative pathology technologies.

Anatomic pathology, a specialty focusing on the diagnosis of diseases through the examination of tissues, organs, and bodily fluids, plays a critical role in cancer detection, inflammatory disease evaluation, and chronic condition management. According to the American Cancer Society (2025), approximately 2 million new cancer cases are estimated in the U.S., further bolstering the demand for anatomic pathology tests, including histopathology, immunohistochemistry, and molecular diagnostics.

Leading market players, such as Cardinal Health, F. Hoffmann-La Roche Ltd., and Leica Microsystems, are focusing on innovative instruments, consumables, and AI-enabled digital pathology solutions to address the growing patient population and demand for early disease detection.

Market Dynamics

Market Drivers

Increasing prevalence of chronic disorders such as cancer, autoimmune disorders, and inflammatory bowel diseases is driving the adoption of anatomic pathology products. According to the CDC (2024), inflammatory bowel disease affects 2.4-3.1 million people in the U.S. Moreover, advancements in early detection and screening, coupled with the integration of artificial intelligence (AI) and digital pathology, are increasing test volumes globally.

Other key growth drivers include:

  • Shift toward precision medicine: Integration of biomarker testing with anatomic pathology enables personalized treatment decisions.
  • Expanding healthcare infrastructure: Growth in hospitals, diagnostic centers, and laboratory modernization projects, particularly in Asia Pacific and Latin America, is increasing market penetration.
  • Supportive reimbursement programs: Governments and insurers are expanding coverage for diagnostic tests, particularly for cancer screening.

Market Restraints

High costs associated with advanced products such as whole-slide imaging systems, microtomes, stainers, and tissue processing systems limit adoption, especially in small and mid-sized labs. Additional operational costs, slide preparation, and regulatory compliance further constrain product penetration.

Market Opportunities

The rising number of oncology-focused clinical trials is creating opportunities for manufacturers and laboratories to collaborate with contract research organizations. Biomarker assessment, tissue-based companion diagnostics, and histopathologic evaluation are increasingly critical in immunotherapy and gene therapy trials, boosting demand for advanced molecular and digital pathology platforms.

Market Challenges

  • Limited diagnosis in developing countries: Delayed referrals, lack of skilled pathologists, and inadequate laboratory infrastructure hinder early detection.
  • Regulatory barriers: Lengthy validation and approval processes for AI-based and molecular pathology solutions slow commercialization.
  • Emergence of substitute technologies: Liquid biopsies and advanced imaging are starting to complement or replace traditional pathology methods.

Market Trends

Technological advancements such as AI, digital pathology, molecular diagnostics, and whole-slide imaging are transforming the market. According to the Mayo Clinic (2025), over 50% of surgical pathology cases were digitized and interpreted through digital platforms, enhancing diagnostic accuracy and workflow efficiency.

Segmentation Analysis

By Type

The market is segmented into products and services. Products, including instruments (microtomes, stainers, tissue processing systems) and consumables, dominated the market with a 63.13% share in 2026, driven by increasing anatomic pathology tests and regulatory approvals.

Example: In May 2024, Indica Labs received FDA approval for HALO AP Dx, a digital platform for primary diagnosis, strengthening its product portfolio.

By Application

  • Disease diagnosis dominated with a 71.64% share in 2026, owing to the rising prevalence of chronic conditions such as cancer and autoimmune disorders.
  • Drug discovery is projected to grow at a 7.7% CAGR.

By Technique

  • Histopathology accounted for 45.62% share in 2026, driven by increasing chronic disease incidence.
  • Molecular pathology is forecasted to grow at 8.3% CAGR, reflecting increasing adoption of advanced diagnostics.

By End User

  • Hospitals & ASCs led the market with a 56.54% share in 2026, supported by the rising number of healthcare facilities and patient pool.
  • Clinical laboratories are projected to grow at 7.7% CAGR.

Regional Outlook

  • North America: Market valued at USD 13.65 billion in 2025, projected to USD 14.63 billion in 2026, with the U.S. accounting for USD 12.69 billion, driven by high test volumes and advanced infrastructure.
  • Europe: Expected to reach USD 9.98 billion in 2026, supported by regulatory compliance, digital pathology adoption, and healthcare access.
  • Asia Pacific: Estimated at USD 11.78 billion in 2026, with India at USD 2.4 billion and China at USD 3.62 billion.
  • Latin America: Projected to reach USD 2.53 billion in 2026.
  • Middle East & Africa: GCC expected at USD 0.37 billion in 2025.

Competitive Landscape

Key players include Cardinal Health, Hoffmann-La Roche Ltd., Avantor Inc., Danaher Corporation, SLMP LLC, Agilent Technologies, Indica Labs, and Hologic Inc. Strategic initiatives such as product launches, FDA approvals, acquisitions, and collaborations support market dominance.

Example: In June 2024, F. Hoffmann-La Roche Ltd. received FDA approval for the VENTANA DP 200 whole-slide imaging system, enhancing global product offerings.

Key Industry Developments

  • September 2025: Labcorp implemented Roche's VENTANA DP 600 and DP 200 scanners.
  • September 2025: StatLab Medical Products launched PiSmart S1 slide printer.
  • July 2025: PathAI introduced its Precision Pathology Network (PPN), powered by AISight 1 IMS.
  • March 2025: Techcyte launched Fusion SaaS platform for unified anatomic and clinical workflows.
  • August 2024: StatLab acquired Diapath S.p.A. to strengthen its market presence.

Conclusion

The global anatomic pathology market is projected to grow from USD 37.74 billion in 2025 to USD 74.04 billion by 2034, at a CAGR of 7.90%, driven by increasing chronic disease prevalence, technological advancements, and expanding healthcare infrastructure. North America leads the market, while emerging regions present significant growth potential. Adoption of AI-enabled digital pathology, molecular diagnostics, and regulatory-approved instruments is expected to drive global market expansion, providing accurate, efficient, and personalized diagnostic solutions across the healthcare spectrum.

Segmentation By Type, Application, Technique, End User, and Region

By Type * Products

    • Instruments
      • Microtomes
      • Tissue Processing Systems
      • Stainers
      • Others
    • Consumables
  • Services

By Application * Disease Diagnosis

  • Drug Discovery
  • Others

By Technique * Histopathology

  • Immunohistochemistry (IHC)
  • In-situ Hybridization
  • Molecular Pathology
  • Others

By End User * Hospitals & ASCs

  • Specialty Clinics
  • Clinical Laboratories
  • Others

By Region * North America (By Type, By Application, By Technique, By End User, and by Country)

    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • U.K. (By Application)
    • Germany (By Application)
    • France (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • China (By Application)
    • Japan (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • Brazil (By Application)
    • Mexico (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Type, By Application, By Technique, By End User, and by Country/Sub-region)
    • GCC (By Application)
    • South Africa (By Application)
    • Rest of the Middle East & Africa (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2026
  • 4.2. New Product Launches, Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Products
      • 5.1.1.1. Instruments
        • 5.1.1.1.1. Microtomes
        • 5.1.1.1.2. Tissue Processing Systems
        • 5.1.1.1.3. Stainers
        • 5.1.1.1.4. Others
      • 5.1.1.2. Consumables
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Disease Diagnosis
    • 5.2.2. Drug Discovery
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Technique
    • 5.3.1. Histopathology
    • 5.3.2. Immunohistochemistry (IHC)
    • 5.3.3. In-situ Hybridization
    • 5.3.4. Molecular Pathology
    • 5.3.5. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Hospitals & ASCs
    • 5.4.2. Specialty Clinics
    • 5.4.3. Clinical Laboratories
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Products
      • 6.1.1.1. Instruments
        • 6.1.1.1.1. Microtomes
        • 6.1.1.1.2. Tissue Processing Systems
        • 6.1.1.1.3. Stainers
        • 6.1.1.1.4. Others
      • 6.1.1.2. Consumables
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Disease Diagnosis
    • 6.2.2. Drug Discovery
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Technique
    • 6.3.1. Histopathology
    • 6.3.2. Immunohistochemistry (IHC)
    • 6.3.3. In-situ Hybridization
    • 6.3.4. Molecular Pathology
    • 6.3.5. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Hospitals & ASCs
    • 6.4.2. Specialty Clinics
    • 6.4.3. Clinical Laboratories
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Application
    • 6.5.2. Canada
      • 6.5.2.1. By Application

7. Europe Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Products
      • 7.1.1.1. Instruments
        • 7.1.1.1.1. Microtomes
        • 7.1.1.1.2. Tissue Processing Systems
        • 7.1.1.1.3. Stainers
        • 7.1.1.1.4. Others
      • 7.1.1.2. Consumables
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Disease Diagnosis
    • 7.2.2. Drug Discovery
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Technique
    • 7.3.1. Histopathology
    • 7.3.2. Immunohistochemistry (IHC)
    • 7.3.3. In-situ Hybridization
    • 7.3.4. Molecular Pathology
    • 7.3.5. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Hospitals & ASCs
    • 7.4.2. Specialty Clinics
    • 7.4.3. Clinical Laboratories
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Application
    • 7.5.2. Germany
      • 7.5.2.1. By Application
    • 7.5.3. France
      • 7.5.3.1. By Application
    • 7.5.4. Spain
      • 7.5.4.1. By Application
    • 7.5.5. Italy
      • 7.5.5.1. By Application
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Application
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Application

8. Asia Pacific Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Products
      • 8.1.1.1. Instruments
        • 8.1.1.1.1. Microtomes
        • 8.1.1.1.2. Tissue Processing Systems
        • 8.1.1.1.3. Stainers
        • 8.1.1.1.4. Others
      • 8.1.1.2. Consumables
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Disease Diagnosis
    • 8.2.2. Drug Discovery
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Technique
    • 8.3.1. Histopathology
    • 8.3.2. Immunohistochemistry (IHC)
    • 8.3.3. In-situ Hybridization
    • 8.3.4. Molecular Pathology
    • 8.3.5. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Hospitals & ASCs
    • 8.4.2. Specialty Clinics
    • 8.4.3. Clinical Laboratories
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Application
    • 8.5.2. Australia
      • 8.5.2.1. By Application
    • 8.5.3. China
      • 8.5.3.1. By Application
    • 8.5.4. India
      • 8.5.4.1. By Application
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Application
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Application

9. Latin America Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Products
      • 9.1.1.1. Instruments
        • 9.1.1.1.1. Microtomes
        • 9.1.1.1.2. Tissue Processing Systems
        • 9.1.1.1.3. Stainers
        • 9.1.1.1.4. Others
      • 9.1.1.2. Consumables
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Disease Diagnosis
    • 9.2.2. Drug Discovery
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Technique
    • 9.3.1. Histopathology
    • 9.3.2. Immunohistochemistry (IHC)
    • 9.3.3. In-situ Hybridization
    • 9.3.4. Molecular Pathology
    • 9.3.5. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Hospitals & ASCs
    • 9.4.2. Specialty Clinics
    • 9.4.3. Clinical Laboratories
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
      • 9.5.1.1. By Application
    • 9.5.2. Mexico
      • 9.5.2.1. By Application
    • 9.5.3. Rest of Latin America
      • 9.5.3.1. By Application

10. Middle East & Africa Anatomic Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Products
      • 10.1.1.1. Instruments
        • 10.1.1.1.1. Microtomes
        • 10.1.1.1.2. Tissue Processing Systems
        • 10.1.1.1.3. Stainers
        • 10.1.1.1.4. Others
      • 10.1.1.2. Consumables
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Disease Diagnosis
    • 10.2.2. Drug Discovery
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Technique
    • 10.3.1. Histopathology
    • 10.3.2. Immunohistochemistry (IHC)
    • 10.3.3. In-situ Hybridization
    • 10.3.4. Molecular Pathology
    • 10.3.5. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Hospitals & ASCs
    • 10.4.2. Specialty Clinics
    • 10.4.3. Clinical Laboratories
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
      • 10.5.1.1. By Application
    • 10.5.2. South Africa
      • 10.5.2.1. By Application
    • 10.5.3. Rest of Middle East & Africa
      • 10.5.3.1. By Application

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Cardinal Health
    • 11.2.2. F. Hoffmann La. Roche Ltd.
    • 11.2.3. Avantor, Inc.
    • 11.2.4. Danaher Corporation
    • 11.2.5. SLMP, LLC.
    • 11.2.6. Agilent Technologies, Inc.
    • 11.2.7. Indica Labs, LLC.
    • 11.2.8. Hologic, Inc.

List of Tables

  • Table 1: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 3: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 4: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 6: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 7: Global Anatomic Pathology Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 8: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 9: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 10: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 11: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 12: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 13: North America Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 14: North America Anatomic Pathology Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: U.S. Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 16: Canada Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 18: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 19: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 20: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 21: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 22: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 23: Europe Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 24: Germany Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 25: U.K. Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 26: France Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 27: Italy Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Spain Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29: Scandinavia Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 30: Rest of Europe Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 31: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 33: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 34: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 36: Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 37: China Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 38: Japan Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 39: India Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 40: Australia Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 41: Southeast Asia Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 42: Rest of Asia Pacific Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 43: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 44: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 45: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 46: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 47: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 48: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 49: Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 50: Brazil Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 51: Mexico Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 52: Rest of Latin America Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 53: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 54: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Products, 2021-2034
  • Table 55: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Instruments, 2021-2034
  • Table 56: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 57: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Technique, 2021-2034
  • Table 58: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by End User, 2021-2034
  • Table 59: Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 60: GCC Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 61: South Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 62: Rest of Middle East & Africa Anatomic Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034

List of Figures

  • Figure 1: Global Anatomic Pathology Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Anatomic Pathology Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Anatomic Pathology Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Anatomic Pathology Market Value Share (%), by Technique, 2025 & 2034
  • Figure 5: Global Anatomic Pathology Market Value Share (%), by End User, 2025 & 2034
  • Figure 6: Global Anatomic Pathology Market Value Share (%), by Region, 2025 & 2034
  • Figure 7: North America Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 8: North America Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 9: North America Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 10: North America Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 11: North America Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 12: North America Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 13: North America Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 14: North America Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 15: North America Anatomic Pathology Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Anatomic Pathology Market Value Share (%), By Country, 2025
  • Figure 17: Europe Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 18: Europe Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 19: Europe Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 20: Europe Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 21: Europe Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 22: Europe Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 23: Europe Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 24: Europe Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 25: Europe Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 28: Asia Pacific Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 29: Asia Pacific Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 30: Asia Pacific Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 31: Asia Pacific Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 32: Asia Pacific Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 33: Asia Pacific Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 34: Asia Pacific Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 35: Asia Pacific Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 38: Latin America Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 39: Latin America Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 40: Latin America Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 41: Latin America Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 42: Latin America Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 43: Latin America Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 44: Latin America Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 45: Latin America Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Anatomic Pathology Market Value (USD billion), by Type, 2025 & 2034
  • Figure 48: Middle East & Africa Anatomic Pathology Market Value Share (%), by Type, 2025
  • Figure 49: Middle East & Africa Anatomic Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 50: Middle East & Africa Anatomic Pathology Market Value Share (%), by Application, 2025
  • Figure 51: Middle East & Africa Anatomic Pathology Market Value (USD billion), by Technique, 2025 & 2034
  • Figure 52: Middle East & Africa Anatomic Pathology Market Value Share (%), by Technique, 2025
  • Figure 53: Middle East & Africa Anatomic Pathology Market Value (USD billion), by End User, 2025 & 2034
  • Figure 54: Middle East & Africa Anatomic Pathology Market Value Share (%), by End User, 2025
  • Figure 55: Middle East & Africa Anatomic Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Anatomic Pathology Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Anatomic Pathology Market Share (%), By Company, 2025